131631-95-3

Upstream product

• 141134-83-0 3,4-dihydro-1-(4-piperidyl)-2(1H)-quinoline hydrochloride 
• 131631-94-2 2-(5-{4-[4-(2-Oxo-3,4-dihydro-2H-quinolin-1-yl)-piperidine-1-carbonyl]-phenoxy}-pentyl)-isoindole-1,3-dione 
• 131631-03-3 1-[1-(4-Acetoxybenzoyl)-4-piperidinyl]-3,4-dihydrocarbostyril 
• 131583-56-7 1-[1-(4-Hydroxy-benzoyl)-piperidin-4-yl]-3,4-dihydro-1H-quinolin-2-one 
• 131587-34-3 3-[2-(1-Benzyl-piperidin-4-ylamino)-phenyl]-propionamide 
• 1664-61-5 dihydrocinnamamide 
• 2345-34-8 4-acetyloxy-benzoic acid 
• 27914-73-4 4-acetoxybenzoyl chloride 

Relevant academic research and scientific papers

Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihydro-2(1H)-quinolinone

A series of compounds has been synthesized and demonstrated to be antagonists of V1 receptors both in vitro and in vivo. These compounds are structurally related to the 1-(4-piperidyl)-2(1H)-quinolinones, including OPC-21268, an orally bioavail

CARBOSTYRIL DERIVATIVES

Novel carbostyril derivatives of the formula: STR1 wherein R 1 is H, NO 2, alkoxy, alkoxycarbonyl, alkyl, halogen, optionally substituted amino, OH, CN, COOH, alkanoyloxy, hydrazinocarbonyl; q is 1 to 3, and R is a group of the formula STR2 [wherein R 2 i